{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:17:16Z","timestamp":1793053036000,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pulsed field ablation (PFA) is a new modality for pulmonary vein isolation (PVI) for atrial fibrillation (AF). PFA is performed under general anaesthetic (GA) or deep sedation with propofol, but this requires anaesthetic support in many countries, restricting use. No study has tested the feasibility of PFA under mild conscious sedation (MCS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We prospectively recruited patients undergoing PFA PVI, offered the option of MCS delivered by electrophysiologists, and compared these with patients who opted for GA. MCS comprised intravenous midazolam and fentanyl. All procedures were performed under anaesthetic supervision in case of requirement to convert to GA, which formed the primary outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Twenty-three patients were recruited (8 MCS, 15 GA). One patient (1\/8 [12.5%]) required conversion from MCS to GA. Total procedural times were similar between groups (MCS 92\u2009\u00b1\u200912.4\u00a0min vs. GA 101\u2009\u00b1\u200917.3\u00a0min; <jats:italic>p<\/jats:italic>\u2009=\u20090.199). High mean sedative doses were required in the MCS group (5.12\u2009\u00b1\u20090.83\u00a0mg midazolam and 209\u2009\u00b1\u200940 mcg fentanyl). Median intraprocedural pain perception by the patient, rated from 0 to 100 was 45 (IQR 22.5\u201372.5) in the MCS group. Post-procedural groin pain (0 [0\u20130] vs. 5 [0\u201335]; <jats:italic>p<\/jats:italic>\u2009=\u20090.027) and throat pain (0 [0\u20130] vs. 10 [5\u201340]; <jats:italic>p<\/jats:italic>\u2009=\u20090.001) were lower in the MCS group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>PFA under MCS is feasible in selected patients but pain and tolerance may be suboptimal, and high sedative doses are required.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1007\/s10840-024-01961-1","type":"journal-article","created":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:16:57Z","timestamp":1733159817000},"page":"1429-1436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Feasibility of pulsed field ablation for atrial fibrillation under mild conscious sedation"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-4033","authenticated-orcid":false,"given":"Peter","family":"Calvert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-7739","authenticated-orcid":false,"given":"Mark T.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ratnasingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3490-090X","authenticated-orcid":false,"given":"Dhiraj","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,2]]},"reference":[{"issue":"18","key":"1961_CR1","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","volume":"389","author":"VY Reddy","year":"2023","unstructured":"Reddy VY, Gerstenfeld EP, Natale A, Whang W, Cuoco FA, Patel C, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med. 2023;389(18):1660\u201371.","journal-title":"N Engl J Med."},{"issue":"1","key":"1961_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.123.064959","volume":"148","author":"MK Turagam","year":"2023","unstructured":"Turagam MK, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A, et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry. Circulation. 2023;148(1):35\u201346.","journal-title":"Circulation"},{"key":"1961_CR3","doi-asserted-by":"publisher","unstructured":"Schmidt B, Bordignon S, Tohoku S, Chen S, Bologna F, Urbanek L, et al. 5S study: safe and simple single shot pulmonary vein isolation with pulsed field ablation using sedation. Circ Arrhythm Electrophysiol. 2022;15(6):e010817. https:\/\/doi.org\/10.1161\/CIRCEP.121.010817.","DOI":"10.1161\/CIRCEP.121.010817"},{"key":"1961_CR4","doi-asserted-by":"crossref","unstructured":"Garcia R, Waldmann V, Vanduynhoven P, Nesti M, Jansen de Oliveira Figueiredo M, Narayanan K, et al. Worldwide sedation strategies for atrial fibrillation ablation: current status and evolution over the last decade. Europace. 2021;23(12):2039\u201345.","DOI":"10.1093\/europace\/euab154"},{"issue":"2","key":"1961_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10840-022-01351-5","volume":"66","author":"G Chu","year":"2022","unstructured":"Chu G, Calvert P, Sidhu B, Mavilakandy A, Kotb A, Tovmassian L, et al. Patient experience of very high power short duration radiofrequency ablation for atrial fibrillation under mild conscious sedation. J Interv Card Electrophysiol. 2022;66(2):445\u201353.","journal-title":"J Interv Card Electrophysiol"},{"issue":"6","key":"1961_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/jce.16269","volume":"35","author":"P Calvert","year":"2024","unstructured":"Calvert P, Koniari I, Mills MT, Ashrafi R, Snowdon R, Gupta D, et al. Lesion metrics and 12-month outcomes of very-high power short duration radiofrequency ablation (90W\/4 s) under mild conscious sedation. J Cardiovasc Electrophysiol. 2024;35(6):1165\u201373.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"1961_CR7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.hrthm.2024.05.032","volume":"21","author":"P Calvert","year":"2024","unstructured":"Calvert P, Mills MT, Xydis P, Essa H, Ding WY, Koniari I, et al. Cost, efficiency and outcomes of pulsed field ablation versus thermal ablation for atrial fibrillation: a real world study. Heart Rhythm. 2024;21(9):1537\u201344.","journal-title":"Heart Rhythm"},{"issue":"1","key":"1961_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/jce.16141","volume":"35","author":"R Wahedi","year":"2024","unstructured":"Wahedi R, Willems S, Feldhege J, Jularic M, Hartmann J, Anwar O, et al. Pulsed-field versus cryoballoon ablation for atrial fibrillation-impact of energy source on sedation and analgesia requirement. J Cardiovasc Electrophysiol. 2024;35(1):162\u201370.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"1961_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.hroo.2022.02.011","volume":"3","author":"L Foerschner","year":"2022","unstructured":"Foerschner L, Harfoush N, Thoma M, Spitzbauer L, Popa M, Bourier F, et al. Deep sedation with propofol in patients undergoing left atrial ablation procedures-is it safe? Heart Rhythm O2. 2022;3(3):288\u201394.","journal-title":"Heart Rhythm O2"},{"issue":"1","key":"1961_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijcard.2013.12.175","volume":"172","author":"A Wutzler","year":"2014","unstructured":"Wutzler A, Mueller A, Loehr L, Huemer M, Parwani AS, Attanasio P, et al. Minimal and deep sedation during ablation of ventricular tachycardia. Int J Cardiol. 2014;172(1):161\u20134.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1961_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10840-013-9817-3","volume":"38","author":"A Wutzler","year":"2013","unstructured":"Wutzler A, Loehr L, Huemer M, Parwani AS, Steinhagen-Thiessen E, Boldt LH, et al. Deep sedation during catheter ablation for atrial fibrillation in elderly patients. J Interv Card Electrophysiol. 2013;38(2):115\u201321.","journal-title":"J Interv Card Electrophysiol"},{"issue":"8","key":"1961_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.recesp.2017.04.016","volume":"71","author":"I Paneque","year":"2018","unstructured":"Paneque I, Calvo-Calvo M\u00c1, Rubio-Guerrero C, Frutos-L\u00f3pez M, Arana-Rueda E, Pedrote A. Deep sedation with propofol administered by electrophysiologists in atrial fibrillation Ablation. Rev Esp Cardiol (Engl Ed). 2018;71(8):683\u20135.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"1961_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1540-8159.2011.03260.x","volume":"35","author":"A Wutzler","year":"2012","unstructured":"Wutzler A, Rolf S, Huemer M, Parwani AS, Boldt LH, Herberger E, et al. Safety aspects of deep sedation during catheter ablation of atrial fibrillation. Pacing Clin Electrophysiol. 2012;35(1):38\u201343.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"1961_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/europace\/eur328","volume":"14","author":"TV Salukhe","year":"2012","unstructured":"Salukhe TV, Willems S, Drewitz I, Steven D, Hoffmann BA, Heitmann K, et al. Propofol sedation administered by cardiologists without assisted ventilation for long cardiac interventions: an assessment of 1000 consecutive patients undergoing atrial fibrillation ablation. Europace. 2012;14(3):325\u201330.","journal-title":"Europace"},{"issue":"3","key":"1961_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/europace\/eur387","volume":"14","author":"J de Bono","year":"2012","unstructured":"de Bono J. Propofol: a safe drug for physician-led procedures? Europace. 2012;14(3):303\u20135.","journal-title":"Europace"},{"issue":"12","key":"1961_CR16","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/j.1540-8167.2011.02120.x","volume":"22","author":"H Kottkamp","year":"2011","unstructured":"Kottkamp H, Hindricks G, Eitel C, M\u00fcller K, Siedziako A, Koch J, et al. Deep sedation for catheter ablation of atrial fibrillation: a prospective study in 650 consecutive patients. J Cardiovasc Electrophysiol. 2011;22(12):1339\u201343.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"5","key":"1961_CR17","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/pace.13063","volume":"40","author":"P M\u00fcnkler","year":"2017","unstructured":"M\u00fcnkler P, Attanasio P, Parwani AS, Huemer M, Boldt LH, Haverkamp W, et al. High patient satisfaction with deep sedation for catheter ablation of cardiac arrhythmia. Pacing Clin Electrophysiol. 2017;40(5):585\u201390.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1961_CR18","doi-asserted-by":"crossref","unstructured":"Verma A, Asivatham SJ, Deneke T, Castellvi Q, Neal RE. Primer on pulsed electrical field ablation: understanding the benefits and limitations. Circ Arrhythm Electrophysiol [Internet]. 2021;14(9):e010086.","DOI":"10.1161\/CIRCEP.121.010086"},{"issue":"2","key":"1961_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.amjcard.2019.04.013","volume":"124","author":"A Vevecka","year":"2019","unstructured":"Vevecka A, Schwab C, Forkmann M, Butz S, Issam A, Turschner O, et al. Predictive factors and safety of noninvasive mechanical ventilation in combination with propofol deep sedation in left atrial ablation procedures. Am J Cardiol. 2019;124(2):233\u20138.","journal-title":"Am J Cardiol"},{"issue":"5","key":"1961_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/pace.12840","volume":"39","author":"P Attanasio","year":"2016","unstructured":"Attanasio P, Huemer M, Shokor Parwani A, Boldt LH, M\u00fcgge A, Haverkamp W, et al. Pain reactions during pulmonary vein isolation under deep sedation: cryothermal versus radiofrequency ablation. Pacing Clin Electrophysiol. 2016;39(5):452\u20137.","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01961-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-024-01961-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01961-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T18:02:04Z","timestamp":1757959324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-024-01961-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,2]]},"references-count":20,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1961"],"URL":"https:\/\/doi.org\/10.1007\/s10840-024-01961-1","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,2]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by our local Research & Innovation Committee and by the National Research Ethics Committee (IRAS 320883). The study was registered on Clinicaltrials.gov prior to commencement (NCT06014814). All patients provided informed written consent for their ablation procedures and for study involvement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"DG reports: Speaker for Boehringer Ingelheim, Biosense Webster, and Boston Scientific; proctor for Abbott; research Grants from Medtronic, Biosense Webster, and Boston Scientific. VL reports: Support from UK National Institute for Health Research scholarship award, speaker for Biosense Webster, research grants from Biosense Webster. BM reports: Previous paid work for Boston Scientific. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}